EVALUATION OF THE ANTICONVULSANT EFFECT OF AQUEOUS EXTRACT OF CENTELLA ASIATICA IN ALBINO MICE
Objective: To evaluate the antiepileptic activity of aqueous extract of Centella asciatica in maximal electroshock (MES) and pentylenetetrazole (PTZ) induced convulsions.
Methods: The anticonvulsant activity of leaves of Centella asciatica (200 mg/kg and 400 mg/kg) in mice was assessed using MES and PTZ induced seizure models. Abolition of tonic hind limb extension (MES and PTZ) and increase in seizure latency (PTZ) when compared to control group, were taken as a measure of protection. Statistical analysis was done using one-way ANOVA followed by Tukey-Kramer multiple comparisons test. The test was considered to be significant at p<0.05.
Results: The aqueous extract of Centella asiatica at a dose of 200 mg/kg has abolished tonic hind limb extension in 1 out of 6 animals in MES while there was no anticonvulsant action in PTZ convulsions. At a dose of 400 mg/kg body weight, the aqueous extract of Centella asiatica has shown a significant anticonvulsant effect against both MES and PTZ convulsions, where it has abolished tonic hind limb extension in 4 mice in MES method and in all 6 mices in PTZ method.
Conclusion: The aqueous extract of Centella asiatica showed efficacy in both MES and PTZ convulsions in mice at a dose of 400 mg/kg. Since the clinical correlates of MES seizures are tonic-clonic convulsions and correlates of PTZ seizures are absence seizures, the aqueous extract of Centella asiatica is likely to be useful in the treatment of tonic-clonic and absence seizures.
2. Ladda PL. Screening of Ricinus communis linn. leaves for anticonvulsant and analgesic activity. Asian J Pharm Clin Res 2014;7:110-4.
3. Epilepsy. (Internet); 2012. Available from: http:// medicaldictionary.thefreedictionary.com/Seizure+disorders. [Last Accessed on 15 Jul 2015]
4. Jain S. The need to launch a global campaign against epilepsy in South East Asia. Neurol Asia 2004;9:74-5.
5. Mitchell S, Taylor L. Diving and epilepsy. (Internet). Available from: www.nzunderwater.org.nz/pdf/NZUA-DivingEpilepsy. pdf. [Last accessed on 25 Dec 2014]
6. Cohen L. Epilepsy as a social problem. Br Med J 1958;2:672-5.
7. Hauser WA, Annegers JF, Kurland LT. The incidence of epilepsy and unprovoked seizures in Rochester. Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
8. Sillanpaa M. Epilepsian epidemiologia. In: Larsen TA and Iivanainen (eds) Epilepsia. Finland: Otava, Keuruu; 1994. p. 42-7.
9. Hauser WA. Incidence and prevalence. In: Engel JJ and Pedley TA. (eds). Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers; 1997. p. 47-58.
10. Vyawahare NS, Khandelwal AR, Batra VR, Andnikam AP. Herbal anticonvulsants. J Herb Med Toxicol 2007;1:9-14.
11. Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB. The anxiogenic activity of Myristica fragrance seeds. Pharmacol Biochem Behav 2002;71:247-52.
12. Raza M, Shaheen F, Choudhary MI, Rahman AU, Sombati S, Suria A, et al. Anticonvulsant effect of FS-1 subfraction isolated from roots of Delphinim Denudatum on hippocampal pyramidal neurons. Phytother Res 2003;17:38-43.
13. Nadkarni AK. Hydrocotyla asiatica Linn. In: Dr. KM Nadkarniâ€™s. Indian Materia Medica. Vol. 1. 3rd edition. Bombay, Popular Book Depot; 1954. p. 663-4.
14. Uppala PK, Krishna BM. Experimental evaluation of anticonvulsant activity of Hydrocotyle asiatica linn (Centella asiatica) in Albino mice. Pharm Biotika 2014;1:59-73.
15. Mittal R. â€œAntiepileptic.â€ In: Gupta SK. Drug screening methods. 1st edition. New Delhi, Jaypee brotherâ€™s medical publishers; 2004. p. 84-103.
16. Toman JEP, Everett GM. â€œAnticonvulsants.â€ In: Laurence DR, Bacharach AL. Evaluation of drug activities: Pharmacometrics. Vol. 1. Academic Press; 1964. p. 287-99.
17. Kupferberg HJ. Antiepileptic drug development program: a cooperative effort of government and industry. Epilepsia 1989;30 Suppl 1:51â€“6.
18. McDonald RL, Kelly KM. Antiepileptic drugs: Mechanisms of action. Epilepsia 1993;34:1-8.